Phospholipase C activity is enhanced in skin fibroblasts obtained from patients with essential hypertension. 2003

Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
Second Department of Internal Medicine, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki 036-8562, Japan.

OBJECTIVE In human hypertension, the response of phospholipase C (PLC) to stimuli is enhanced in signal transduction where receptors are coupled to pertussis toxin-sensitive G protein. We investigated PLC activity and its role in human hypertension. RESULTS Skin fibroblasts were cultured from 15 normotensives subjects (53 +/- 4 years, four men and 11 women) and 19 essential hypertension (EH) patients (58 +/- 2 years, nine men and 10 women). Plasma membrane PLC activity, assessed by conversion of the tritiated exogenous phosphatidylinositol-4,5-bisphosphate to inositol trisphosphate, was greater in EH patients than in normotensive subjects (1.4 +/- 0.2 versus 0.7 +/- 0.1 pmol/mg protein/min, P <0.05). There was a positive correlation between PLC activity and mean blood pressure measured at admission and 7 days after admission (r = 0.47 and 0.37 respectively, both P <0.05). The value of the Michaelis constant was lower in EH patients than in normotensive subjects (32.1 +/- 5.6 versus 58.3 +/- 10.0 micromol/l, P <0.05), despite the fact that maximal velocity of the reaction was no different. Western blot analysis against PLC beta2 and beta3, gamma, delta1, and G protein gamma2 and gamma5 revealed that most PLC and G protein isoforms detected were delta1 of PLC and gamma2 of G protein, and no difference was detected in their amount between two groups. CONCLUSIONS We conclude that enhanced PLC delta1 activity may be involved in the pathogenesis of human hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010738 Type C Phospholipases A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS. Lecithinase C,Phospholipase C,Phospholipases, Type C,Phospholipases C
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
January 1987, Enzyme,
Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
January 1983, Annals of clinical and laboratory science,
Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
January 2013, Connective tissue research,
Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
April 1990, Hypertension (Dallas, Tex. : 1979),
Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
February 1987, International journal of clinical pharmacology, therapy, and toxicology,
Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
March 1986, Arthritis and rheumatism,
Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
August 1995, The Journal of clinical investigation,
Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
January 1985, Regulatory peptides. Supplement,
Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
March 1995, Hypertension (Dallas, Tex. : 1979),
Takuo Kosugi, and Tomohiro Osanai, and Takaatsu Kamada, and Takao Nakano, and Ken Okumura
May 2002, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!